Given the ERα-dependent classification of breast cancers into two major subtypes (ER-positive and ER-negative), we naïvely expected that a quantitative characterization of the ERα–GATA3 network would reveal a bistable switch (45,46,53–58). This evidence concerns the gene GATA3 and breast cancer.